We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

71 hedge funds and large institutions have $795M invested in Cullinan Oncology in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

1% more funds holding

Funds holding: 70 → 71 (+1)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1.55% less ownership

Funds ownership: 75.66% → 74.11% (-1.6%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

39% less capital invested

Capital invested by funds: $1.3B → $795M (-$504M)

Holders
71
Holders Change
+1
Holders Change %
+1.43%
% of All Funds
1.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
18
Increased
22
Reduced
19
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIG
American International Group
New York
+$37.6M
2
DM
Deerfield Management
New York
+$32.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
IC
Ikarian Capital
Texas
+$9.06M
5
Franklin Resources
Franklin Resources
California
+$8.89M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$30.2M
2
APM
Avidity Partners Management
Texas
-$29.5M
3
VC
Vivo Capital
California
-$10.4M
4
BI
BVF Inc
California
-$9.66M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$3.18M +$2.26M +73,634 +148%
Citadel Advisors
27
Citadel Advisors
Florida
$2.65M -$253K -8,214 -7%
AG
28
Artal Group
Luxembourg
$2.58M – – –
Charles Schwab
29
Charles Schwab
California
$2.31M +$100K +3,268 +4%
Adage Capital Partners
30
Adage Capital Partners
Massachusetts
$2.01M -$8.11M -263,731 -77%
Marshall Wace
31
Marshall Wace
United Kingdom
$1.93M +$2.3M +74,951 New
Morgan Stanley
32
Morgan Stanley
New York
$1.71M +$2.03M +65,964 +17,134%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.55M -$114K -3,714 -6%
BC
34
Birchview Capital
Vermont
$1.16M -$461K -15,000 -25%
AAA
35
Affinity Asset Advisors
New York
$1.16M +$1.38M +45,000 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.02M +$148K +4,802 +14%
BFM
37
Boothbay Fund Management
New York
$1.01M +$1.2M +39,113 New
Victory Capital Management
38
Victory Capital Management
Texas
$837K -$66.1K -2,150 -6%
Swiss National Bank
39
Swiss National Bank
Switzerland
$736K +$880K +28,600 New
Renaissance Technologies
40
Renaissance Technologies
New York
$669K +$799K +25,982 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$470K -$47.6K -1,549 -8%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$388K +$464K +15,072 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$387K +$106K +3,443 +30%
Bank of America
44
Bank of America
North Carolina
$376K -$268K -8,699 -37%
DFCM
45
Dark Forest Capital Management
Puerto Rico
$365K +$436K +14,172 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$355K +$424K +13,800 New
Goldman Sachs
47
Goldman Sachs
New York
$318K -$1.34M -43,707 -78%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$304K +$105K +3,404 +41%
CS
49
Credit Suisse
Switzerland
$233K +$278K +9,031 New
Deutsche Bank
50
Deutsche Bank
Germany
$214K -$8.06K -262 -3%
1
2
3 4

CGEM Hedge Fund Activity: Q2 2021 in Review

71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q2 2021, worth a combined $795M — down 39% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CGEM positions and 17 closed out — a net gain of 1 holder — while 22 added to existing stakes and 19 trimmed.

The largest buyer was American International Group, adding an estimated $37.6M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $30.2M sold.

  • 71 institutional investors held Cullinan Oncology (CGEM) as of Q2 2021, up from 70 in Q1 2021.
  • Funds reported $795M of Cullinan Oncology stock for Q2 2021, down 39% quarter-over-quarter.
  • 18 funds opened new Cullinan Oncology positions in Q2 2021 and 17 closed out, a net change of +1 holder.
  • The largest Cullinan Oncology buyer in Q2 2021 was American International Group, an estimated $37.6M added.
  • The largest Cullinan Oncology seller in Q2 2021 was T. Rowe Price Associates, an estimated $30.2M sold.

Based on aggregated 13F filings for Q2 2021.